开发和验证一种病理升级预测模型,用于低度胃粘膜发育不良
Alternative therapies in health and medicine
|June 28, 2024
概括
一种使用AMACR染色的新模型显著改善了低度胃力发育不良 (LGD) 病理升级的预测. 这种增强的模型提供了更准确的预后,有助于早期干预,并改善患者对LGD管理的结果.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 胃粘膜中的低度发育不良 (LGD) 存在病理升级的风险.
- 准确预测LGD升级对于有效的患者管理和治疗策略至关重要.
研究的目的:
- 开发和比较一个传统的预测模型与一个增强的模型结合α-methylacyl-CoA赛马酶 (AMACR) 染色,以预测胃LGD的病理升级.
- 评估增强模型的性能和临床实用性.
主要方法:
- 用405个LGD病例的培训数据集来开发和比较传统和增强的预测模型.
- 改进的模型包含了活检组织的AMACR染色.
- 模型性能使用曲线下的面积 (AUC),引导重新抽样和决策曲线分析进行评估,对171个案例进行外部验证.
主要成果:
- 传统模型实现了0.824的AUC,用于预测病理升级.
- 采用AMACR染色的增强模型表现出显著改善的性能,AUC为0.878.8.
- 包括AMACR染色导致AUC在0.054.5的统计学上显著增加.
结论:
- 结合AMACR染色的增强预测模型显著改善了胃LGD病理升级的预测.
- 这种增强的模型有可能完善LGD患者的管理和治疗策略.
- 利用AMACR染色可以提高诊断准确性,可能减少术后病理升级,改善早期胃癌检测.
相关概念视频
Barrett Esophagus-I: Introduction
83
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
83
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
109
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
109
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
374
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
374
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


